Abstract View

Author(s): Shashidhar*1, Dhanya Bappanad2

Email(s): 1shashidharhasgond0689@gmail.com

Address:

    Srinivas College of Pharmacy, Valachil, Mangalore, Karnataka State, India

Published In:   Volume - 4,      Issue - 10,     Year - 2025

DOI: https://doi.org/10.71431/IJRPAS.2025.41001  

 View HTML        View PDF

Please allow Pop-Up for this website to view PDF file.

ABSTRACT:
Pharmacy practice is experiencing a significant transformation, shifting from traditional roles focused on medication dispensing to a more advanced, patient-centered, and clinically integrated model. This review examines the changing responsibilities of pharmacists and how these evolving roles positively influence therapeutic outcomes and overall healthcare delivery. Notable progress includes the expansion of clinical pharmacy services, implementation of medication therapy management (MTM), involvement in public health activities, integration of digital technologies, and the authorization to prescribe medications in various settings. These changes have made pharmacists essential in managing chronic conditions, supporting medication adherence, preventing hospital admissions, and promoting public health. However, barriers such as restrictive regulations, lack of reimbursement structures, limited collaboration with other healthcare professionals, and low public awareness still hinder full utilization of their capabilities. Looking ahead, the profession is expected to advance through standardization of clinical services, increased participation in primary care teams, and the use of emerging technologies like artificial intelligence and big data. Strengthening pharmacy practice through supportive legislation, ongoing training, and greater recognition is crucial to enhancing patient-centered care and building a more effective and accessible global healthcare system.

Cite this article:
Shashidhar, Dhanya Bappanad.Optimizing Patient Outcomes Through Evolving Roles in Pharmacy Practice: A Review of Current Trends and Future Directions. IJRPAS, October 2025; 4(10): 1-5.DOI: https://doi.org/https://doi.org/10.71431/IJRPAS.2025.41001


1. Greer N, Bolduc J, Geurkink E, et al. Pharmacist‑led Chronic Disease Management: A Systematic Review…Ann Intern Med. 2016;164(9):678–87.

2. Al‑Dossari DS, Laghbi YA, Almutairi AS, et al. Impact of telepharmacy on patients’ outcome during COVID‑19: a systematic review. Pharm Pract 2023;21(4):2883.

3. Pathak S, Blanchard CM, Moreton E, Urick BY. A Systematic Review of Telepharmacy Services in Community Pharmacies. J Health Care Poor Underserved. 2021;32(2):737‑50.

4. Pathak S, Haynes M, Qato DM, Urick BY. Telepharmacy and Quality of Medication Use in Rural Areas, 2013‑2019. Prev Chronic Dis. 2020;17:E101.

5. Merten JA, Shapiro JF, Gulbis AM, et al. Utilization of Collaborative Practice Agreements between Physicians and Pharmacists…Biol Blood Marrow Transplant. 2013 Apr;19(4):S17.

6. Leventhal J. The right medicine for the rural doctor shortage. InsideSources. Jan 2025.

7. Al Ammari M, AlThiab K, Al Johani M. Tele‑pharmacy Anticoagulation Clinic During COVID‑19 Pandemic: Patient Outcomes. Front Pharmacol. 2021;12:652482.

8. Tran RJC, Yamzon J, Stewart TL, et al. Effectiveness of Telepharmacy Versus Face‑to‑Face Anticoagulation Services. Ann Pharmacother. 2020;55(9):1084‑1095.

9. JAPhA study. Impact of a clinical pharmacist‑led, AI‑supported chronic care program. J Pharmaceut Health Serv Res. 2024.

10. Van de Sande L, et al. Standardizing Clinical Pharmacy Services…ASHP J Pharm Pract. 2023.

11. Bond CA, Raehl CL. Clinical pharmacy services and adverse drug reactions in US hospitals. Pharmacotherapy. 2006;26(6):735‑47.

12. Friesner DL, Scott DM, et al. Do remote community telepharmacies have higher medication error rates? J Am Pharm Assoc. 2011;51(5):580‑90.

13. Ibrahim OM, Ibrahim RM, Abdel‑Qader DH, et al. Role of telepharmacy in pharmacist counseling to COVID‑19 patients. J Telemed Telecare. 2021;27(6):649‑56.

14. Hefti E, Wei B, Engelen K. Access to Telepharmacy Services May Reduce Hospital Admissions in Outpatients. Telemed e-Health. 2022;28(9):1324‑31.

15. SAGE Journals. A systematic review of synchronous telepharmacy service models. 2024.

16. Verywellhealth.com. How Your Pharmacist Can Help You With Your Chronic Condition. 2024.

17. Washington Post. Taking too many prescription drugs can be very risky for older people. Jun 2025.

18. Shim J, et al. Telepharmacy and pharmaceutical care: narrative review. Farm Hosp. 2023;47(3):100‑7.

19. JAPhA. Telepharmacy and remote medication management. 2024.

20. Collaborative Practice Agreement. Wikipedia. May 2025.

21. Comprehensive Medication Management. Wikipedia. 2023.

22. Mohamed Ibrahim O, et al. Evaluation of telepharmacy services in COVID‑19. Telemed J E Health. 2021;27(6):649‑656.

Related Images:



Recent Images



Assessing Philippine Health Care Coverage Gaps: An Assessment of Accessibility of Public Health Programs in Selected Barangay in Imus, Cavite, Philippines
Isoabsorptive UV Spectrophotometry Method development and validation for simultaneous estimation of Eslicarbazepine Acetate and Carbamazepine
To develop and validate the stability indicating method for repaglinide and voglibose using HPLC method
To develop and validate the stability indicating method for Empagliflozin and Linagliptin using HPLC method
A Prospective Observational Study on the Clinical Evaluation of Vertigoin Young Adult Population of Amaravati Capital Region
Quality by Design-Based Analytical Method Development and Validation of Suzetrigine by RP - HPLC
Formulation, Optimization and Evaluation of Rimegepant Pulsatile Tablets for Chronotherapeutic Management of Migraine
Development and Evaluation of Ticagrelor Solid Dispersion Tablets Using PVP K30, PEG 6000 and HPMC E5 for Dissolution Enhancement
To study the effect of various superdisintegrants and binders in the Formulation and Evaluation of Labetalol Rapid Disintegrating Tablet
To Develop and Validate the Stability Indicating Method for Ezetimibe and Rosuvastatin Using HPLC Method

Tags